Oct 24, 2022, 11:20 by

RGHI raise awareness for good hygiene on World Polio Day 24th October

Oct 24, 2022, 11:20 by

Oct 24, 2022, 11:19 by

Oct 24, 2022, 11:19 by

About INCOG BioPharma Services Designed to deliver better. Discover the INCOG way. We designed and built INCOG BioPharma based on decades of experience with a clear purpose: to deliver better CDMO services in the injectable drug product space. The company’s service offering includes filling drug product into vials, syringes, and cartridges. INCOG BioPharma also offers support services to include formulation development, analytical development, stability testing and storage, and final inspection, labeling, packaging, and device assembly. With our dedicated team, best-in-class processes, and state-of-the-art equipment, we deliver meaningful results and stand-out customer experiences. We stand behind our motto, “in it with you,” from the moment we start work on your project. We go above and beyond to understand your requirements, meet your needs, and foster a truly collaborative partnership. For more information, visit www.incogbiopharma.com and follow us at INCOG BioPharma Services on LinkedIn.

Oct 21, 2022, 09:28 by

Celegence, a global provider of regulatory affairs services for the life sciences industry, is pleased to announce that Navignostics, a global developer of drug mechanisms designed to identify ideal treatments for cancer patients, has selected Celegence’s CAPTIS™ technology solution to support Performance Evaluation Reports and other PMS documentation in compliance with the In-Vitro Diagnostic Regulation (IVDR).

Oct 21, 2022, 09:27 by

The expansion will increase development and manufacturing for small molecules at the Södertälje facility with new equipment and increased capabilities to strengthen the firm’s existing expertise in drug substance manufacture.

Oct 20, 2022, 10:19 by

A robust telomere aging clocks system combined with RF, qPCR, STELA, and TESLA techniques is newly reconfigured to conduct specialized lab-grade telomere length analysis and offer comprehensive pictures of biological aging.

Oct 20, 2022, 10:19 by

NDA Group has announced the expansion of the NDA Advisory Board with the appointment of Sigrid Klaar M.D., Ph.D., specialist in oncology.

Oct 20, 2022, 10:15 by

Tillotts Pharma AG has announced the recent launch of Octasa® 800mg (mesalazine) delayed-release tablets, as first-line treatment for moderately active ulcerative colitis (UC) in Canada.

Oct 20, 2022, 10:14 by

END Contact information For media enquiries, please contact Imogen Quail, PR Manager, at ramarketing: imogen.quail@ramarketingpr.com, +44 (0)191 222 1242, ramarketingpr.com, Twitter: @ramarketingpr, Facebook: /ramarketingpr, LinkedIn: /ramarketing About Recipharm Recipharm is a leading Contract Development and Manufacturing Organisation (CDMO) in the pharmaceutical industry employing almost 9,000 employees. Recipharm offers manufacturing services of pharmaceuticals in various dosage forms, production of clinical trial material and APIs, pharmaceutical product development and development and manufacturing of medical devices. Recipharm manufactures several hundred different products to customers ranging from big pharma to smaller research and development companies. The company operates development and manufacturing facilities in France, Germany, India, Israel, Italy, Portugal, Spain, Sweden, the UK and the US and is headquartered in Stockholm, Sweden. For more information on Recipharm and our services, please visit www.recipharm.com 1Source Safety Prefilled Syringe Market Size is expected to reach (globenewswire.com) Recipharm AB Corporate identity number 556498-8425 Address Box 603, SE-101 32 Stockholm, Sweden, Telephone +46 8 602 52 00 www.recipharm.com

Oct 20, 2022, 10:08 by

Oct 20, 2022, 10:08 by

Creative Diagnostics announced the launch of Monkeypox Virus Antigens and Antibodies to support scientists focused on the research of monkeypox virus.

Oct 20, 2022, 10:08 by

Amerigo Scientific recently announced the launch of its new PicoRaman Spectrometer for biological and pharmaceutical applications.

Oct 20, 2022, 10:07 by

STEMart has recently introduced Biological Indicator Sterility Testing services for the industry of medical devices.

Oct 20, 2022, 01:00 by User Not Found

Clinical Research News | For patients with lung cancer, meeting the eligibility criteria for clinical trials has been a major roadblock to their participation. Over time, studies have grown more complex and expensive and sponsors, eager to optimize the scientific yield of a trial, have become incredibly strict about who meets the enrollment requirements.

Oct 19, 2022, 15:56 by

ytel Inc. has entered into an agreement to acquire SDS Life Science AB and SDS MedteQ AB.

Oct 19, 2022, 15:56 by

Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), announced today it has successfully renewed its ISO 27001 certification (Information Security Management System) and obtained ISO 27017 certification (Information Security in cloud services) and ISO 37001 certification (Anti-bribery management systems).

Oct 19, 2022, 15:56 by

Known for its competence, responsibility, and innovative capability in chemical supply, Alfa Chemistry recently unveiled its new role as a CDMO service provider for pharmaceutical companies worldwide.

Oct 19, 2022, 15:56 by

New functionality added to advanced dossier management solution to bring greater efficiencies to eCTD compliance

Oct 19, 2022, 15:56 by

Indica Labs and Hamamatsu Photonics K.K. have announced an agreement to maintain long-term interoperability between Indica Lab’s HALO AP® software platform and Hamamatsu’s NanoZoomer family of high-speed, high-resolution scanners.